🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
1.510
-0.100 (-6.21%)
Nov 19, 2026, 4:00 PM EST - Market closed

Polaryx Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Cash & Equivalents
8.445.144.620
Cash & Short-Term Investments
8.445.144.620
Cash Growth
46.91%11.30%230950.00%-
Prepaid Expenses
0.15-0.382.31
Other Current Assets
0.020.03--
Total Current Assets
8.615.1752.32
Total Assets
8.615.1752.32

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Accounts Payable
0.780.470.070.47
Accrued Expenses
0.220.140.220.44
Short-Term Debt
---0.13
Total Current Liabilities
10.610.291.04
Total Liabilities
10.610.291.04

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Common Stock
0.010.0100
Additional Paid-In Capital
114.49104.295.3661.57
Retained Earnings
-106.89-99.64-90.65-60.29
Shareholders' Equity
7.614.574.711.28
Total Liabilities & Equity
8.615.1752.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Total Debt
---0.13
Net Cash (Debt)
8.445.144.62-0.13
Net Cash Growth
46.91%11.30%--
Net Cash Per Share
0.180.110.14-0.01
Filing Date Shares Outstanding
49.8547.3441.1510.69
Total Common Shares Outstanding
49.8547.3441.1510.69
Working Capital
7.614.574.711.28
Book Value Per Share
0.150.100.110.12
Tangible Book Value
7.614.574.711.28
Tangible Book Value Per Share
0.150.100.110.12
SEC Filings: 10-K · 10-Q